Literature DB >> 2475963

Identification of ovine interferons: differential activities derived from fibroblast and lymphoid cells.

G Entrican1, D M Haig, M Norval.   

Abstract

A bioassay has been developed to detect interferon (IFN) activity in supernatant fluids of cultured sheep cells by measuring their ability to inhibit the cytopathic effect of Semliki Forest Virus on an immortalised ovine fibroblastic cell line. IFN produced by spleen or lymph node cells stimulated with mitogen was labile at pH 2 as was a similar activity produced by CD4 lymphocytes stimulated with mitogen or specific antigen. In contrast, the IFN produced by fibroblasts stimulated with synthetic double-stranded RNA was stable at that pH. These results demonstrate the existence of an ovine IFN with properties similar to those described for IFN-gamma in mouse and man.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475963     DOI: 10.1016/0165-2427(89)90066-4

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  4 in total

1.  The orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible, double-stranded RNA-dependent kinase.

Authors:  D M Haig; C J McInnes; J Thomson; A Wood; K Bunyan; A Mercer
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

2.  Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2.

Authors:  D Deane; C J McInnes; A Percival; A Wood; J Thomson; A Lear; J Gilray; S Fleming; A Mercer; D Haig
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  The importance of interferon-gamma in an early infection of Chlamydia psittaci in mice.

Authors:  M C McCafferty; S W Maley; G Entrican; D Buxton
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

4.  Cytokine release by ovine macrophages following infection with Chlamydia psittaci.

Authors:  G Entrican; R Wilkie; P McWaters; J Scheerlinck; P R Wood; J Brown
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.